Jazz Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	14,915	10,444	7,467	7,657	10,071	7,852
Market Cap Growth	119.41%	39.87%	-2.49%	-23.96%	28.26%	-15.31%
Enterprise Value	17,458	13,411	10,621	11,803	14,985	13,398
Last Close Price	237.72	170.00	123.15	123.00	159.31	127.40
PE Ratio	506.42	-	14.24	20.16	-	-
Forward PE	9.64	7.67	5.72	6.29	8.54	8.23
PEG Ratio	0.17	0.55	0.37	0.50	1.14	0.62
PS Ratio	3.36	2.45	1.84	2.00	2.75	2.54
PB Ratio	3.29	2.42	1.82	2.05	3.26	1.98
P/FCF Ratio	11.75	8.05	5.50	7.17	8.10	10.46
P/OCF Ratio	11.18	7.70	5.35	7.01	7.92	10.09
EV/Sales Ratio	3.93	3.14	2.61	3.08	4.10	4.33
EV/EBITDA Ratio	8.69	50.41	7.72	9.70	26.57	18.54
EV/EBIT Ratio	13.48	-	14.82	20.40	-	78.68
EV/FCF Ratio	13.75	10.34	7.82	11.05	12.06	17.84
Debt / Equity Ratio	0.96	1.01	1.49	1.38	1.87	1.54
Debt / EBITDA Ratio	8.00	20.33	4.47	4.74	10.28	8.49
Debt / FCF Ratio	4.26	4.17	4.53	5.40	4.66	8.17
Net Debt / Equity Ratio	0.56	0.69	0.77	1.11	1.59	1.40
Net Debt / EBITDA Ratio	3.74	11.15	2.29	3.41	8.72	7.67
Net Debt / FCF Ratio	1.99	2.29	2.32	3.88	3.95	7.39
Asset Turnover	0.38	0.36	0.35	0.34	0.32	0.33
Inventory Turnover	1.25	1.12	0.83	0.66	0.61	0.78
Quick Ratio	1.65	1.46	3.57	1.52	1.64	1.43
Current Ratio	2.04	1.86	4.46	2.24	2.79	3.23
Return on Equity (ROE)	0.67%	-8.45%	14.35%	12.25%	-6.07%	-8.63%
Return on Assets (ROA)	0.04%	-2.06%	7.31%	7.30%	-0.33%	5.27%
Return on Invested Capital (ROIC)	0.06%	-2.93%	10.13%	9.05%	-0.38%	6.35%
Return on Capital Employed (ROCE)	-0.40%	-4.22%	6.88%	5.86%	-0.61%	1.96%
Earnings Yield	0.20%	-	7.02%	4.96%	-	-
FCF Yield	8.51%	12.42%	18.19%	13.95%	12.34%	9.56%
Buyback Yield / Dilution	5.13%	7.61%	8.41%	-15.23%	-4.77%	-5.62%
Total Shareholder Return	5.13%	7.61%	8.41%	-15.23%	-4.77%	-5.62%

SEC Filings: 10-K · 10-Q